Stay updated on Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added related topics Head and neck squamous cell carcinoma and MedlinePlus Genetics, and updated the page revision from v3.2.0 to v3.3.2.
    Difference
    0.2%
    Check dated 2025-11-25T14:42:57.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The government funding lapse notice about NIH operations has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:29:51.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Head and neck squamous cell carcinoma and the related topic MedlinePlus Genetics were removed from the page's related topics. This affects how the study is categorized and surfaced in topic-based searches.
    Difference
    0.2%
    Check dated 2025-11-03T22:02:01.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    MedlinePlus Genetics related topics: Head and neck squamous cell carcinoma was added to the page. This provides an external consumer health information link but does not affect the study details.
    Difference
    0.9%
    Check dated 2025-10-27T21:10:25.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Adds a new MedlinePlus Genetics topic on head and neck squamous cell carcinoma to the page content.
    Difference
    0.4%
    Check dated 2025-10-13T12:30:18.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 and added a government-operating-status notice; removed the v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T08:30:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Post-op Radiotherapy in CSCC Clinical Trial page.